Estrogen Receptor Modulators

"Estrogen Receptor Modulators" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Substances that possess antiestrogenic actions but can also produce estrogenic effects as well. They act as complete or partial agonist or as antagonist. They can be either steroidal or nonsteroidal in structure.

Descriptor ID	D020847
MeSH Number(s)	D06.347.360 D27.505.696.399.450.360
Concept/Terms	Estrogen Receptor Modulators Estrogen Receptor Modulators Modulators, Estrogen Receptor Receptor Modulators, Estrogen Antiestrogens Antiestrogen Estrogen Receptor Modulator Modulator, Estrogen Receptor Receptor Modulator, Estrogen

Below are MeSH descriptors whose meaning is more general than "Estrogen Receptor Modulators".

Chemicals and Drugs [D]
Hormones, Hormone Substitutes, and Hormone Antagonists [D06]
Hormone Antagonists [D06.347]
Estrogen Receptor Modulators [D06.347.360]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Physiological Effects of Drugs [D27.505.696]
Hormones, Hormone Substitutes, and Hormone Antagonists [D27.505.696.399]
Hormone Antagonists [D27.505.696.399.450]
Estrogen Receptor Modulators [D27.505.696.399.450.360]

Below are MeSH descriptors whose meaning is related to "Estrogen Receptor Modulators".

Below are MeSH descriptors whose meaning is more specific than "Estrogen Receptor Modulators".

Estrogen Receptor Modulators
Selective Estrogen Receptor Modulators

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Estrogen Receptor Modulators" by people in this website by year, and whether "Estrogen Receptor Modulators" was a major or minor topic of these publications.

Bar chart showing 14 publications over 9 distinct years, with a maximum of 3 publications in 2009

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2003	1	0	1
2005	1	1	2
2007	1	0	1
2008	2	0	2
2009	2	1	3
2011	1	0	1
2013	1	0	1
2014	1	1	2
2018	1	0	1

Below are the most recent publications written about "Estrogen Receptor Modulators" by people in Profiles.

Doyle BJ, Lawal TO, Locklear TD, Hernandez L, Perez AL, Patel U, Patel S, Mahady GB. Isolation and identification of three new chromones from the leaves of Pimenta dioica with cytotoxic, oestrogenic and anti-oestrogenic effects. Pharm Biol. 2018 Dec; 56(1):235-244.

View in: PubMed
Ko NY, Darnell JS, Calhoun E, Freund KM, Wells KJ, Shapiro CL, Dudley DJ, Patierno SR, Fiscella K, Raich P, Battaglia TA. Can patient navigation improve receipt of recommended breast cancer care? Evidence from the National Patient Navigation Research Program. J Clin Oncol. 2014 Sep 01; 32(25):2758-64.

View in: PubMed
Mosquera L, Col?n JM, Santiago JM, Torrado AI, Mel?ndez M, Segarra AC, Rodr?guez-Orengo JF, Miranda JD. Tamoxifen and estradiol improved locomotor function and increased spared tissue in rats after spinal cord injury: their antioxidant effect and role of estrogen receptor alpha. Brain Res. 2014 May 02; 1561:11-22.

View in: PubMed
Garon EB, Pietras RJ, Finn RS, Kamranpour N, Pitts S, M?rquez-Garb?n DC, Desai AJ, Dering J, Hosmer W, von Euw EM, Dubinett SM, Slamon DJ. Antiestrogen fulvestrant enhances the antiproliferative effects of epidermal growth factor receptor inhibitors in human non-small-cell lung cancer. J Thorac Oncol. 2013 Mar; 8(3):270-8.

View in: PubMed
Sellin Jeffries MK, Conoan NH, Cox MB, Sangster JL, Balsiger HA, Bridges AA, Cowman T, Knight LA, Bartelt-Hunt SL, Kolok AS. The anti-estrogenic activity of sediments from agriculturally intense watersheds: assessment using in vivo and in vitro assays. Aquat Toxicol. 2011 Sep; 105(1-2):189-98.

View in: PubMed
Suzuki N, Liu X, Laxmi YR, Okamoto K, Kim HJ, Zhang G, Chen JJ, Okamoto Y, Shibutani S. Anti-breast cancer potential of SS5020, a novel benzopyran antiestrogen. Int J Cancer. 2011 Feb 15; 128(4):974-82.

View in: PubMed
Laxmi YR, Liu X, Suzuki N, Kim SY, Okamoto K, Kim HJ, Zhang G, Chen JJ, Okamoto Y, Shibutani S. Anti-breast cancer potential of SS1020, a novel antiestrogen lacking estrogenic and genotoxic actions. Int J Cancer. 2010 Oct 01; 127(7):1718-26.

View in: PubMed
Zimmermann MC, Tilghman SL, Bou? SM, Salvo VA, Elliott S, Williams KY, Skripnikova EV, Ashe H, Payton-Stewart F, Vanhoy-Rhodes L, Fonseca JP, Corbitt C, Collins-Burow BM, Howell MH, Lacey M, Shih BY, Carter-Wientjes C, Cleveland TE, McLachlan JA, Wiese TE, Beckman BS, Burow ME. Glyceollin I, a novel antiestrogenic phytoalexin isolated from activated soy. J Pharmacol Exp Ther. 2010 Jan; 332(1):35-45.

View in: PubMed
Miller TW, P?rez-Torres M, Narasanna A, Guix M, St?l O, P?rez-Tenorio G, Gonzalez-Angulo AM, Hennessy BT, Mills GB, Kennedy JP, Lindsley CW, Arteaga CL. Loss of Phosphatase and Tensin homologue deleted on chromosome 10 engages ErbB3 and insulin-like growth factor-I receptor signaling to promote antiestrogen resistance in breast cancer. Cancer Res. 2009 May 15; 69(10):4192-201.

View in: PubMed
M?rquez-Garb?n DC, Chen HW, Goodglick L, Fishbein MC, Pietras RJ. Targeting aromatase and estrogen signaling in human non-small cell lung cancer. Ann N Y Acad Sci. 2009 Feb; 1155:194-205.

View in: PubMed

People

Explore

Similar Concepts

Top Journals